Damaged neurons leak proteins into bodily fluids, creating potential markers for neurodegenerative diseases including Alzheimer's. But one such prospect might be less clear-cut a measure of AD ...

CSF-ctDNA was detected in 59% of cases and showed high concordance (84%) with tumor mutations. Lower variant allelic frequency in CSF-ctDNA was associated with significantly worse survival outcomes.

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer Patients with NSCLC who had CSF collection ...

Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and therapeutic targets that may unlock advancements in Alzheimer’s diagnosis and care. Study: ...

An analysis of cerebrospinal fluid has uncovered several proteins likely involved in the development and progression of Alzheimer's disease. The study, published in the journal Nature Genetics, ...

“These exciting new data from coAAV-CSF-01 represent a major step forward in CNS gene therapy,” said Lolita Petit, CSO of Coave Therapeutics. “In non-human primates, the vector achieved robust brain ...

Neurological disorders affect hundreds of millions of people worldwide, representing a leading cause of death and imposing a significant long-term burden due to years lived with disability. 1 Despite ...

TOKYO and CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate ...